Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04869618 | Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric Cancer | unknown | N/A | 100 | Changi General HospitalOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT04819958 | The Effect of Immunological Heterogeneity of Tumor Microenvironment in the Prognosis of Gastric Cancer | unknown | — | 20 | Fujian Medical UniversityOTHER | 1 | Apr 15, 2021 |
| NCT04835246 | Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions | unknown | N/A | 185 | Endofotonics Pte LtdINDUSTRY | 1 | Apr 15, 2021 | clinicaltrials |
| NCT04843397 | Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study(PROSPERO) | unknown | — | 1,000 | University of CambridgeOTHER | 0 | Apr 15, 2021 | clinicaltrials |
| NCT04393584 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma(RusGCG-01) | unknown | Phase 2 / Phase 3 | 538 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT04442984 | FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)(IRIGA) | unknown | Phase 2 | 326 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT03874871 | Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients | unknown | — | 300 | Peking UniversityOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT02901301 | Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer | unknown | Phase 1 / Phase 2 | 41 | Yonsei UniversityOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT02752698 | Domestic Surgical Robot Clinical Study | unknown | N/A | 200 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04826107 | Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer | unknown | Phase 2 | 196 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 0 | Apr 1, 2021 | clinicaltrials |
| NCT04810663 | Outcome of Radiation Therapy in Operated Gastric Cancer | unknown | — | 40 | Assiut UniversityOTHER | 0 | Mar 23, 2021 | clinicaltrials |
| NCT04563975 | Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 54 | Tao ZhangOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04797923 | A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination | unknown | Phase 2 | 43 | Gangnam Severance HospitalOTHER | 1 | Mar 15, 2021 | clinicaltrials |
| NCT04792515 | Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer(CCWSA/OAFLAG) | unknown | Phase 2 | 67 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT04777162 | Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04781413 | Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer | unknown | Phase 1 / Phase 2 | 38 | Ruijin HospitalOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04778345 | Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer | unknown | N/A | 72 | Fujian Medical UniversityOTHER | 1 | Mar 3, 2021 | clinicaltrials |
| NCT03322969 | Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04764084 | Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors | unknown | Phase 1 | 52 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT03257280 | Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015) | unknown | N/A | 84 | Hospital Universitari de BellvitgeOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT03941626 | Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies | unknown | Phase 1 / Phase 2 | 50 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Feb 4, 2021 | clinicaltrials |
| NCT02500199 | Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors | unknown | Phase 1 | 50 | Hengrui Therapeutics, Inc.INDUSTRY | 1 | Feb 1, 2021 | clinicaltrials |
| NCT04486651 | HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer | unknown | Phase 3 | 560 | Taizhou Hanzhong biomedical co. LTDINDUSTRY | 1 | Jan 28, 2021 | clinicaltrials |
| NCT01359397 | Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer(B-DOCT) | unknown | Phase 2 | — | The Netherlands Cancer InstituteOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04720521 | Application of OE in Diagnosis of EGC | unknown | N/A | 2,454 | Changhai HospitalOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT04624282 | Metabonomics Study of Chronic Gastritis and Gastric Carcinoma | unknown | — | 60 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04270890 | Investigation of an Abdominal Compression Device(ACE02) | unknown | N/A | 30 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT04136600 | EGFR Monoclonal Antibody for Advanced Gastric Cancer | unknown | Phase 2 | 100 | Shanghai Changzheng HospitalOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT03154983 | The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer | unknown | Phase 2 | 48 | Zhou FuxiangOTHER | 1 | Dec 9, 2020 | clinicaltrials |
| NCT04657848 | Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy | unknown | N/A | 100 | Zhejiang Cancer HospitalOTHER | 1 | Dec 8, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04652986 | Outcomes of Laparoscopic Gastrectomy | unknown | — | 100 | Juan Carlos Martín del OlmoOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04641455 | Use of Mucolytic Solution Before Upper Endoscopy | unknown | N/A | 120 | Vitkovice HospitalOTHER | 1 | Nov 23, 2020 | clinicaltrials |
| NCT04638959 | Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC | unknown | — | 1,100 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT00927680 | Familial Colorectal Cancer Registry in Hispanics(PURIFICAR) | unknown | — | 5,000 | University of Puerto RicoOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT04631757 | Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | unknown | Phase 2 | 33 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 17, 2020 | clinicaltrials |
| NCT03478449 | The Criteria for Lymph Node Sorting for Pathological Examination in Gastric Cancer | unknown | N/A | 276 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04294589 | Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events(Flownet) | unknown | — | 250 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 10, 2020 | clinicaltrials |
| NCT02640898 | Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric Cancer | unknown | N/A | 500 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 27, 2020 | clinicaltrials |
| NCT02595086 | Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy(KLASS-04) | unknown | N/A | 256 | Seoul National University HospitalOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT04576858 | Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer(CURE) | unknown | — | 1,950 | Rigshospitalet, DenmarkOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04567069 | Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment | unknown | Phase 1 / Phase 2 | 45 | The Second Hospital of Shandong UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT04411589 | The Diagnostic Ability of White Light Endoscopy and Magnifying Endoscopy With Optical Enhancement System | unknown | N/A | 300 | Shandong UniversityOTHER | 1 | Sep 25, 2020 | clinicaltrials |
| NCT04484311 | Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia(NC-ESD) | unknown | — | 300 | Universidade do PortoOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT04555304 | Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy | unknown | Phase 2 | 81 | Chengdu Kanghong Biotech Co., Ltd.INDUSTRY | 0 | Sep 18, 2020 | clinicaltrials |
| NCT02333721 | Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer(LSPLN) | unknown | N/A | 536 | Fujian Medical UniversityOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04526483 | L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System | unknown | N/A | 67 | Shanghai Minimally Invasive Surgery CenterOTHER | 0 | Aug 25, 2020 | clinicaltrials |
| NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | unknown | Phase 2 | 136 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Aug 24, 2020 | clinicaltrials |
| NCT04522011 | Comparison of the Efficiency Between Intraoperative and Postoperative Hyperthermic Intraperitoneal Chemotherapy With Docetaxel Combine Oxaliplatin in Patients With Advanced Gastric Cancer | unknown | — | 200 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 21, 2020 | clinicaltrials |
Data updated 23 days agoSource updated May 3, 2021source: clinicaltrials